SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : PSFT - Fiscal 1998 - Discussion for the next year -- Ignore unavailable to you. Want to Upgrade?


To: Lizzie Tudor who wrote (4359)1/28/1999 9:15:00 PM
From: Chuzzlewit  Respond to of 4509
 
Michelle, remember Levitt's letter to 150 tech companies concerning write-offs for "in process R&D". I don't know if that's the issue. If it is something else, that raises a really ugly specter. Let's wait for management to tell us something more. I haven't had a chance to read the income statement yet.

CTC



To: Lizzie Tudor who wrote (4359)1/28/1999 9:33:00 PM
From: Chuzzlewit  Read Replies (2) | Respond to of 4509
 
Michelle, here is the pertinent section:

The Company is currently responding to a comment letter from the SEC related to its accounting for the PMAN acquisition in 1996, and is clearing with the SEC its accounting for the Intrepid acquisition completed in the fourth quarter of 1998. In both cases, the SEC is reviewing the charge to In Process Research and Development in light of recent guidance from the SEC on valuation of purchase accounting for acquisitions. Upon completion of the SEC review, the Company may be required to restate its financial statements of 1996, 1997 and 1998 to reflect a lower In Process R&D write-down from 1996 for PMAN, and/or to change the In Process R&D write-down taken in the fourth quarter of 1998 for Intrepid. The Company believes its accounting for PMAN was proper and in accordance with GAAP and with industry practices in effect in 1996, and the Company's calculation of the adjustment required to reflect the recent SEC guidelines show that any adjustment would not be material to the financial statements of 1996, 1997 or 1998. The Company also believes that its accounting for Intrepid in the fourth quarter of 1998 is in accordance with the SEC's recent guidelines. However, there can be no assurance that the SEC comments once issued will not require a material change in reported earnings of 1996, 1997, or 1998 related to the accounting for the PMAN or Intrepid acquisitions.

Just as I thought. Note thre things: first, these changes have no affect on taxes, revenue recognition and the like. They simply relate to how the costs of completing in process R&D are recogized. Second. as a consequnece of this not being an issue with the IRS, there is no affect whatsoever on cash flow. Finally, the report indicates that the effect will be small.

I don't think this issue will be a big deal. More troubling to me are reduced forecasts and RIFs.

TTFN,
CTC